XTNT Fundamental Analysis - XTANT MEDICAL HOLDINGS INC

Fundamental Rating

Overall XTNT gets a fundamental rating of 3 out of 10. We evaluated XTNT against 190 industry peers in the Health Care Equipment & Supplies industry. XTNT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, XTNT is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

XTNT had negative earnings in the past year.

In the past year XTNT had a positive cash flow from operations.

In the past 5 years XTNT reported 4 times negative net income.

In the past 5 years XTNT reported 4 times negative operating cash flow.

1.2 Ratios

XTNT has a better Return On Assets (-4.43%) than 66.32% of its industry peers.

XTNT's Return On Equity of -9.44% is fine compared to the rest of the industry. XTNT outperforms 66.32% of its industry peers.

The Return On Invested Capital of XTNT (0.03%) is better than 65.26% of its industry peers.

		Industry Rank	Sector Rank
ROA	-4.43%
ROE	-9.44%
ROIC	0.03%

ROA(3y)-10.3%

ROA(5y)-11.34%

ROE(3y)-20.61%

ROE(5y)-25.18%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

XTNT's Operating Margin of 0.02% is fine compared to the rest of the industry. XTNT outperforms 65.26% of its industry peers.

XTNT's Gross Margin of 60.16% is fine compared to the rest of the industry. XTNT outperforms 60.53% of its industry peers.

In the last couple of years the Gross Margin of XTNT has declined.

		Industry Rank	Sector Rank
OM	0.02%
PM (TTM)	N/A
GM	60.16%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.35%

GM growth 5Y-2.41%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XTNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

The number of shares outstanding for XTNT has been increased compared to 1 year ago.

The number of shares outstanding for XTNT has been increased compared to 5 years ago.

XTNT has a worse debt/assets ratio than last year.

2.2 Solvency

XTNT has an Altman-Z score of -0.51. This is a bad value and indicates that XTNT is not financially healthy and even has some risk of bankruptcy.

XTNT has a Altman-Z score of -0.51. This is comparable to the rest of the industry: XTNT outperforms 41.05% of its industry peers.

XTNT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.

XTNT's Debt to Equity ratio of 0.46 is in line compared to the rest of the industry. XTNT outperforms 45.79% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.46
Debt/FCF	N/A
Altman-Z	-0.51

ROIC/WACC0

WACC8.95%

2.3 Liquidity

XTNT has a Current Ratio of 2.47. This indicates that XTNT is financially healthy and has no problem in meeting its short term obligations.

XTNT's Current ratio of 2.47 is in line compared to the rest of the industry. XTNT outperforms 50.00% of its industry peers.

XTNT has a Quick Ratio of 1.16. This is a normal value and indicates that XTNT is financially healthy and should not expect problems in meeting its short term obligations.

XTNT has a worse Quick ratio (1.16) than 70.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.47
Quick Ratio	1.16

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for XTNT have decreased strongly by -100.00% in the last year.

The Revenue has grown by 15.16% in the past year. This is quite good.

The Revenue has been growing by 12.64% on average over the past years. This is quite good.

EPS 1Y (TTM)-100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%166.67%

Revenue 1Y (TTM)15.16%

Revenue growth 3Y28.5%

Revenue growth 5Y12.64%

Sales Q2Q%18.26%

3.2 Future

XTNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.30% yearly.

XTNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.31% yearly.

EPS Next Y108.5%

EPS Next 2Y42.92%

EPS Next 3Y30.31%

EPS Next 5YN/A

Revenue Next Year10.6%

Revenue Next 2Y0.34%

Revenue Next 3Y3.31%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XTNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 153.33, which means the current valuation is very expensive for XTNT.

Compared to the rest of the industry, the Price/Forward Earnings ratio of XTNT indicates a somewhat cheap valuation: XTNT is cheaper than 66.32% of the companies listed in the same industry.

When comparing the Price/Forward Earnings ratio of XTNT to the average of the S&P500 Index (23.09), we can say XTNT is valued expensively.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	153.33

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XTNT is valued a bit cheaper than the industry average as 71.05% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	30.42

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

A more expensive valuation may be justified as XTNT's earnings are expected to grow with 30.30% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y42.92%

EPS Next 3Y30.31%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for XTNT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

XTANT MEDICAL HOLDINGS INC

NYSEARCA:XTNT (10/22/2025, 6:40:00 PM)

After market: 0.799 +0.02 (+2.17%)

0.782

+0 (+0.26%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-12 2025-08-12/bmo

Earnings (Next)10-30 2025-10-30/bmo

Inst Owners57.12%

Inst Owner Change0%

Ins Owners14.93%

Ins Owner Change-0.26%

Market Cap109.48M

Revenue(TTM)127.77M

Net Income(TTM)-4581000

Analysts85

Price Target1.79 (128.9%)

Short Float %0.06%

Short Ratio0.84

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)198.04%

Min EPS beat(2)100%

Max EPS beat(2)296.08%

EPS beat(4)2

Avg EPS beat(4)77.12%

Min EPS beat(4)-56.86%

Max EPS beat(4)296.08%

EPS beat(8)3

Avg EPS beat(8)73.86%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)2

Avg Revenue beat(2)7.07%

Min Revenue beat(2)3.39%

Max Revenue beat(2)10.74%

Revenue beat(4)2

Avg Revenue beat(4)1.19%

Min Revenue beat(4)-6.52%

Max Revenue beat(4)10.74%

Revenue beat(8)6

Avg Revenue beat(8)5.84%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)150%

EPS NY rev (3m)128.57%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)4.81%

Revenue NY rev (1m)0%

Revenue NY rev (3m)1.25%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	153.33
P/S	0.86
P/FCF	N/A
P/OCF	72.94
P/B	2.26
P/tB	3.25
EV/EBITDA	30.42

EPS(TTM)-0.04

EYN/A

EPS(NY)0.01

Fwd EY0.65%

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)0.01

OCFY1.37%

SpS0.91

BVpS0.35

TBVpS0.24

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.43%
ROE	-9.44%
ROCE	0.04%
ROIC	0.03%
ROICexc	0.03%
ROICexgc	0.04%
OM	0.02%
PM (TTM)	N/A
GM	60.16%
FCFM	N/A

ROA(3y)-10.3%

ROA(5y)-11.34%

ROE(3y)-20.61%

ROE(5y)-25.18%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.35%

GM growth 5Y-2.41%

F-Score5

Asset Turnover1.23

Health

		Industry Rank	Sector Rank
Debt/Equity	0.46
Debt/FCF	N/A
Debt/EBITDA	4.97
Cap/Depr	97.07%
Cap/Sales	3.39%
Interest Coverage	0.01
Cash Conversion	33.42%
Profit Quality	N/A
Current Ratio	2.47
Quick Ratio	1.16
Altman-Z	-0.51

F-Score5

WACC8.95%

ROIC/WACC0

Cap/Depr(3y)93.26%

Cap/Depr(5y)102.58%

Cap/Sales(3y)2.72%

Cap/Sales(5y)2.97%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%166.67%

EPS Next Y108.5%

EPS Next 2Y42.92%

EPS Next 3Y30.31%

EPS Next 5YN/A

Revenue 1Y (TTM)15.16%

Revenue growth 3Y28.5%

Revenue growth 5Y12.64%

Sales Q2Q%18.26%

Revenue Next Year10.6%

Revenue Next 2Y0.34%

Revenue Next 3Y3.31%

Revenue Next 5YN/A

EBIT growth 1Y100.21%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year230.8%

EBIT Next 3Y49%

EBIT Next 5YN/A

FCF growth 1Y74.12%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y116.46%

OCF growth 3YN/A

OCF growth 5YN/A

XTANT MEDICAL HOLDINGS INC (XTNT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens